↓ Skip to main content

TACE plus lenvatinib and tislelizumab for intermediate-stage hepatocellular carcinoma beyond up-to-11 criteria: a multicenter cohort study

Overview of attention for article published in Frontiers in immunology, July 2024
Altmetric Badge

Mentioned by

twitter
1 X user

Citations

dimensions_citation
1 Dimensions
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
TACE plus lenvatinib and tislelizumab for intermediate-stage hepatocellular carcinoma beyond up-to-11 criteria: a multicenter cohort study
Published in
Frontiers in immunology, July 2024
DOI 10.3389/fimmu.2024.1430571
Pubmed ID
Authors

Song Chen, Tang Shuangyan, Feng Shi, Hongjie Cai, Zhiqiang Wu, Liguang Wang, Ping Ma, Yuanmin Zhou, Qicong Mai, Fan Wang, Jiaming Lai, Xiaoming Chen, Huanwei Chen, Wenbo Guo

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 27 July 2024.
All research outputs
#23,843,428
of 26,538,769 outputs
Outputs from Frontiers in immunology
#28,855
of 33,363 outputs
Outputs of similar age
#182,832
of 233,904 outputs
Outputs of similar age from Frontiers in immunology
#374
of 605 outputs
Altmetric has tracked 26,538,769 research outputs across all sources so far. This one is in the 1st percentile – i.e., 1% of other outputs scored the same or lower than it.
So far Altmetric has tracked 33,363 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.6. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 233,904 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 605 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.